本页面由Tiger Trade Technology Pte. Ltd.提供服务

Adaptimmune Therapeutics plc

0.0549
0.0000
成交量:- -
成交额:- -
市值:1,455.13万
市盈率:-0.08
高:0.0549
开:0.0549
低:0.0549
收:0.0549
52周最高:0.8100
52周最低:0.0403
股本:2.65亿
流通股本:1.83亿
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.6574
每股收益(LYR):-0.2807
净资产收益率:-1341.10%
总资产收益率:-40.86%
市净率:-0.21
市盈率(LYR):-0.20

数据加载中...

2025/10/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/10/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/10/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/10/28

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025/10/20

重要事件披露

Form 8-K - Current report
2025/09/26

重要事件披露

Form 8-K - Current report
2025/09/12

重要事件披露

Form 8-K - Current report
2025/09/09

重要事件披露

Form 8-K - Current report
2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/29

重要事件披露

Form 8-K - Current report
2025/08/15

重要事件披露

Form 8-K - Current report
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

重要事件披露

Form 8-K - Current report
2025/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report
2025/08/08

重要事件披露

Form 8-K - Current report
2025/07/31

重要事件披露

Form 8-K - Current report
2025/07/28

重要事件披露

Form 8-K - Current report